Nephronomics
Biotechnology Research • 
Greater Boston, MA, United States • 1-10 Employees
Company overview
| Headquarters | Greater Boston, MA, United States |
| Website | |
| NAICS | 541714 |
| Keywords | Genomic Research, Ai/Llm, Cardio-Kidney-Metabolic |
| Founded | 2023 |
| Employees | 1-10 |
Key Contact at Nephronomics
James Sietstra
Founder
About Nephronomics
Nephronomics, a joint venture with Fresenius Medical Care, is a precision medicine company vertically integrating the world's most robust cardio-kidney-metabolic disease database of clinical and genomic data and ML models to develop targeted therapies against the underlying molecular mechanisms. The genetic component of CKM disease remains significantly underappreciated in clinical practice. Through exclusive access to the My Reason® dataset with >35,000 patients, we're building the leading CKM disease model to discover new disease subtypes as well as both protective and disease-causing variants across the cardio-kidney-metabolic spectrum. The Nephronomics Atlas enables the best powered and most comprehensive studies to discover protective and disease-causing variants in CKM disease, addressing the complex interrelationship between cardiovascular disease, kidney dysfunction, and metabolic disorders that often occur together.
Nephronomics revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Nephronomics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Nephronomics has never raised funding before.
Ireland
United Kingdom
Saudi Arabia
Australia
Frequently asked questions
4.8
40,000 users
